250 related articles for article (PubMed ID: 35371018)
1. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
Clanchy FIL; Huang YS; Ogbechi J; Darlington LG; Williams RO; Stone TW
Front Immunol; 2022; 13():832989. PubMed ID: 35371018
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
3. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
[TBL] [Abstract][Full Text] [Related]
5. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.
Campia I; Buondonno I; Castella B; Rolando B; Kopecka J; Gazzano E; Ghigo D; Riganti C
PLoS One; 2015; 10(5):e0126159. PubMed ID: 25955018
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
[TBL] [Abstract][Full Text] [Related]
7. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA
Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.
Gomes B; Driessens G; Bartlett D; Cai D; Cauwenberghs S; Crosignani S; Dalvie D; Denies S; Dillon CP; Fantin VR; Guo J; Letellier MC; Li W; Maegley K; Marillier R; Miller N; Pirson R; Rabolli V; Ray C; Streiner N; Torti VR; Tsaparikos K; Van den Eynde BJ; Wythes M; Yao LC; Zheng X; Tumang J; Kraus M
Mol Cancer Ther; 2018 Dec; 17(12):2530-2542. PubMed ID: 30232146
[TBL] [Abstract][Full Text] [Related]
9. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
[TBL] [Abstract][Full Text] [Related]
10. Role of indoleamine 2,3-dioxygenase in health and disease.
Yeung AW; Terentis AC; King NJ; Thomas SR
Clin Sci (Lond); 2015 Oct; 129(7):601-72. PubMed ID: 26186743
[TBL] [Abstract][Full Text] [Related]
11. Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production.
Bellucci M; Pompa A; De Marcos Lousa C; Panfili E; Orecchini E; Maricchiolo E; Fraternale D; Orabona C; De Marchis F; Pallotta MT
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065885
[TBL] [Abstract][Full Text] [Related]
12. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process.
Salminen A
Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834
[TBL] [Abstract][Full Text] [Related]
13. Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers
Yang C; Ng CT; Li D; Zhang L
Front Immunol; 2021; 12():725204. PubMed ID: 34539663
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.
Majumdar T; Sharma S; Kumar M; Hussain MA; Chauhan N; Kalia I; Sahu AK; Rana VS; Bharti R; Haldar AK; Singh AP; Mazumder S
Cell Death Dis; 2019 Feb; 10(3):161. PubMed ID: 30770800
[TBL] [Abstract][Full Text] [Related]
15. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.
Pallotta MT; Orabona C; Bianchi R; Vacca C; Fallarino F; Belladonna ML; Volpi C; Mondanelli G; Gargaro M; Allegrucci M; Talesa VN; Puccetti P; Grohmann U
J Cell Mol Med; 2014 Oct; 18(10):2082-91. PubMed ID: 25215657
[TBL] [Abstract][Full Text] [Related]
16. Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer.
Passarelli A; Pisano C; Cecere SC; Di Napoli M; Rossetti S; Tambaro R; Ventriglia J; Gherardi F; Iannacone E; Venanzio SS; Fiore F; Bartoletti M; Scognamiglio G; Califano D; Pignata S
Front Immunol; 2022; 13():953115. PubMed ID: 36119020
[TBL] [Abstract][Full Text] [Related]
17. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.
Song X; Si Q; Qi R; Liu W; Li M; Guo M; Wei L; Yao Z
Front Immunol; 2021; 12():800630. PubMed ID: 35003126
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine in IDO1
Ying X; Zheng X; Zhang X; Yin Y; Wang X
J Transl Med; 2024 Mar; 22(1):267. PubMed ID: 38468343
[TBL] [Abstract][Full Text] [Related]
20. Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase.
Fuertig R; Azzinnari D; Bergamini G; Cathomas F; Sigrist H; Seifritz E; Vavassori S; Luippold A; Hengerer B; Ceci A; Pryce CR
Brain Behav Immun; 2016 May; 54():59-72. PubMed ID: 26724575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
